VEGFB (VEGF2) (AA 110-139) antibody

Catalog No. ABIN3029577

The Rabbit Polyclonal anti-VEGFB (VEGF2) antibody (ABIN3029577) specifically detects VEGFB (VEGF2) in WB, ELISA and IHC. The antibody is reactive with Human samples.

Quick Overview for VEGFB (VEGF2) (AA 110-139) antibody (ABIN3029577)

Target: VEGFB (VEGF2)

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: Un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Product Details

Binding Specificity: AA 110-139

Purification: Purified

Immunogen: A portion of amino acids 110-139 from the human protein was used as the immunogen for this VEGFB antibody.

Isotype: Ig Fraction

Application Details

Application Notes: Titration of the VEGFB antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,IHC (Paraffin): 1:10-1:50

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: In 1X PBS pH 7.4 with 0.09 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Aliquot the VEGFB antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Target Details

Target: VEGFB (VEGF2)

Background: Vascular endothelial growth factors (VEGFs) are a family of closely related growth factors having a conserved pattern of eight cysteine residues and sharing common VEGF receptors. VEGFs stimulate endothelial cells, induce angiogenesis, promote cell migration, increase vascular permeability, and inhibit apoptosis. VEGFB has structural similarities to VEGF and PIGF and is frequently co-expressed with VEGF. There are two alternatively spliced isoforms of VEGFB: VEGFB 167 and VEGFB 186. VEGFB 167, a highly basic heparin-binding protein, remains with the cell or extracellular matrix whereas, VEGFB 186 is readily secreted. VEGFB stimulates endothelial cell proliferation. VEGFB binds to the tyrosine kinase receptor VEGFR1 (flt1) and does not bind to VEGFR2. Vascular Endothelial Growth Factor B is widely expressed but is most abundant in heart, skeletal muscle, and pancreas. It has been suggested that VEGFB expression in human primary breast cancers is associated with lymph node metastasis. The genes that encode VEGFB have been mapped to chromosome 11q13.

UniProt: P49765